Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors

被引：953

作者：

Rendic, S ^{[1
]}

DiCarlo, FJ ^{[1
]}

机构：

[1] US EPA, HERD 7403, WASHINGTON, DC 20460 USA

来源：

关键词：

D O I：

10.3109/03602539709037591

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：413 / 580

页数：168

共 512 条

[1] ABOLFATHI Z, 1995, CLIN PHARMACOL THER, V57, P221
[2] ADEDOYIN A, 1995, CLIN PHARMACOL THER, V57, P150
[3] METABOLISM OF AMINOPYRINE AND DERIVATIVES IN MAN - IN-VIVO STUDY OF MONOMORPHIC AND POLYMORPHIC METABOLIC PATHWAYS
AGUNDEZ, JAG
MARTINEZ, C
BENITEZ, J
[J]. XENOBIOTICA, 1995, 25 (04) : 417 - 427
[4] Ahmed S, 1995, Drug Des Discov, V13, P27
[5] Paroxetine shifts imipramine metabolism
Albers, LJ
Reist, C
Helmeste, D
Vu, R
Tang, SW
[J]. PSYCHIATRY RESEARCH, 1996, 59 (03) : 189 - 196
[6] ANDERSSON P, 1993, ISSX P 5 N AM ISSX M, V4, P236
[7] IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM
ANDERSSON, T
MINERS, JO
VERONESE, ME
BIRKETT, DJ
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (06) : 597 - 604
[8] BAILEY DG, 1995, BRIT J CLIN PHARMACO, V40, P135
[9] BAILEY DG, 1994, CLIN PHARMACOL THER, V55, P165
[10] KETOCONAZOLE AND SULFAPHENAZOLE AS THE RESPECTIVE SELECTIVE INHIBITORS OF P4503A AND 2C9
BALDWIN, SJ
BLOOMER, JC
SMITH, GJ
AYRTON, AD
CLARKE, SE
CHENERY, RJ
[J]. XENOBIOTICA, 1995, 25 (03) : 261 - 270